AMGN · US market

Amgen Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$220.18bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E25.18×
Latest-quarter run-rate P/E23.18×
Trailing P/S5.78×
Latest-quarter run-rate P/S5.48×

Calculation inputs

Trailing earnings
US$8.74bn
Latest-quarter run-rate earnings
US$9.50bn
Latest fiscal-year earnings
US$7.71bn
Trailing revenue
US$38.10bn
Latest-quarter run-rate revenue
US$40.22bn
Latest fiscal-year revenue
US$36.75bn

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • BBH · VanEck Biotech ETF15.25% weight · Holdings dated 30 June 2026
  • IBB · iShares Biotechnology ETF8.40% weight · Holdings dated 19 August 2026
  • WOGSX · White Oak Select Growth Fund5.03% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • LOGSX · Live Oak Health Sciences Fund4.95% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • DIA · SPDR Dow Jones Industrial Average ETF Trust4.91% weight · Holdings dated 19 August 2026
  • PJP · Invesco Pharmaceuticals ETF4.79% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • SVFAX · Smead Value Fund Class A4.74% weight · Holdings dated 29 May 2026
  • IBBQ · Invesco Nasdaq Biotechnology ETF4.71% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PBE · Invesco Biotechnology & Genome ETF4.71% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • POGSX · Pin Oak Equity Fund4.42% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.